In just over two months the NHS said it had given 124,867 RSV vaccinations to eligible pregnant woman and elderly people, who ...

Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe ...

It's recommended that everyone 75 and older should get the RSV vaccine. Everyone 60 and older with a chronic condition may be ...